{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:16Z","timestamp":1741238656141,"version":"3.38.0"},"reference-count":24,"publisher":"JLE","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1684\/ejd.2018.3402","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:15:07Z","timestamp":1696864507000},"page":"661-667","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Positive margins after surgical excision of locoregional cutaneous melanoma metastasis and their impact on patient outcome"],"prefix":"10.1684","volume":"28","author":[{"given":"Barbara","family":"Bregeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Varey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaelle","family":"Quereux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Saint-Jean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Peuvrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Khammari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Dreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"3402_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"3402_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/bjd.12687","volume":"170","author":"ZV Fong","year":"2014","unstructured":"Fong ZV, Tanabe KK. Comparison of melanoma guidelines in the USA, Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review. Br J Dermatol 2014; 170: 20\u201330.","journal-title":"Br J Dermatol"},{"key":"3402_CR3","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong S\u2013J, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199\u2013206.","journal-title":"J Clin Oncol"},{"key":"3402_CR4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence\u2013based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017; 67: 472\u201392.","journal-title":"CA Cancer J Clin"},{"key":"3402_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00000658-198307000-00013","volume":"198","author":"DF Roses","year":"1983","unstructured":"Roses DF, Harris MN, Rigel D, Carrey Z, Friedman R, Kopf AW. Local and in\u2013transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg 1983; 198: 65\u20139.","journal-title":"Ann Surg"},{"key":"3402_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1200\/JCO.1997.15.3.1039","volume":"15","author":"AC Buzaid","year":"1997","unstructured":"Buzaid AC, Ross MI, Balch CM, et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997; 15: 1039\u201351.","journal-title":"J Clin Oncol"},{"key":"3402_CR7","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1245\/s10434-009-0353-4","volume":"16","author":"CM Balch","year":"2009","unstructured":"Balch CM. Microscopic satellites around a primary melanoma: another piece of the puzzle in melanoma staging. Ann Surg Oncol 2009; 16: 1092\u20134.","journal-title":"Ann Surg Oncol"},{"key":"3402_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archderm.141.6.739","volume":"141","author":"L Shaikh","year":"2005","unstructured":"Shaikh L, Sagebiel RW, Ferreira CMM, Nosrati M, Miller JR, Kashani\u2013Sabet M. The role of microsatellites as a prognostic factor in primary malignant melanoma. Arch Dermatol 2005; 141: 739\u201342.","journal-title":"Arch Dermatol"},{"key":"3402_CR9","doi-asserted-by":"publisher","first-page":"63137","DOI":"10.1371\/journal.pone.0063137","volume":"8","author":"B Weide","year":"2013","unstructured":"Weide B, Faller C, B\u00fcttner P, et al. Prognostic factors of melanoma patients with satellite or in\u2013transit metastasis at the time of stage III diagnosis. PLoS One 2013; 8: e63137.","journal-title":"PLoS One"},{"key":"3402_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1468-3083.2012.04454.x","volume":"27","author":"F Messeguer","year":"2013","unstructured":"Messeguer F, Agust\u00ed\u2013Mej\u00edas A, Traves V, et al. Mitotic rate and subcutaneous involvement are prognostic factors for survival after recurrence in patients with only locoregional skin metastasis as the first site of recurrence from cutaneous melanoma: survival after locoregional skin metastasis. J Eur Acad Dermatol Venereol 2013; 27: 436\u201341.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3402_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/CMR.0b013e32835a310c","volume":"22","author":"NJ Suoj\u00e4rvi","year":"2012","unstructured":"Suoj\u00e4rvi NJ, Jahkola TA, Virolainen S, Ilmonen SK, Hernberg MM. Outcome following local recurrence or in\u2013transit metastases in cutaneous melanoma. Melanoma Res 2012; 22: 447\u201353.","journal-title":"Melanoma Res"},{"key":"3402_CR12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.6004\/jnccn.2016.0051","volume":"14","author":"DG Coit","year":"2016","unstructured":"Coit DG, Thompson JA, Algazi A, et al. Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2016; 14: 450\u201373.","journal-title":"J Natl Compr Canc Netw"},{"key":"3402_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.soc.2010.09.008","volume":"20","author":"RS Turley","year":"2011","unstructured":"Turley RS, Raymond AK, Tyler DS. Regional treatment strategies for in\u2013transit melanoma metastasis. Surg Oncol Clin N Am 2011; 20: 79\u2013103.","journal-title":"Surg Oncol Clin N Am"},{"key":"3402_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00000658-197410000-00029","volume":"180","author":"DL Morton","year":"1974","unstructured":"Morton DL, Eilber FR, Holmes EC, et al. BCG immunotherapy of malignant melanoma: summary of a seven\u2013year experience. Ann Surg 1974; 180: 635\u201343.","journal-title":"Ann Surg"},{"key":"3402_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2217\/imt.15.35","volume":"7","author":"DB Johnson","year":"2015","unstructured":"Johnson DB, Puzanov I, Kelley MC. Talimogene laherparepvec (T\u2013VEC) for the treatment of advanced melanoma. Immunotherapy 2015; 7: 611\u20139.","journal-title":"Immunotherapy"},{"key":"3402_CR16","doi-asserted-by":"crossref","first-page":"37893","DOI":"10.18632\/oncotarget.9247","volume":"7","author":"H Liu","year":"2016","unstructured":"Liu H, Innamarato PP, Kodumudi K, et al. Intralesional Rose Bengal in melanoma elicits tumor immunity via activation of dendritic cells by the release of high mobility group box 1. Oncotarget 2016; 7: 37893\u2013905.","journal-title":"Oncotarget"},{"key":"3402_CR17","first-page":"1340","volume":"25","author":"TE Grotz","year":"2011","unstructured":"Grotz TE, Mansfield AS, Erickson LA, Otley CC, Markovic SN, Jakub JW. In\u2013transit melanoma: an individualized approach. Oncology 2011; 25: 1340.","journal-title":"Oncology"},{"key":"3402_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jdcr.2016.01.004","volume":"2","author":"JS Leventhal","year":"2016","unstructured":"Leventhal JS, Odell ID, Imaeda S, Maverakis E, King BA. Treatment of melanoma in\u2013transit metastases with combination intralesional interleukin\u20132, topical imiquimod, and tretinoin 0.1% cream. JAAD Case Rep 2016; 2: 114\u20136.","journal-title":"JAAD Case Rep"},{"key":"3402_CR19","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1245\/s10434-017-5803-9","volume":"24","author":"MF Madu","year":"2017","unstructured":"Madu MF, Deken MM, van der Hage JA, J\u00f3\u017awiak K, Wouters MWJM, van Akkooi ACJ. Isolated limb perfusion for melanoma is safe and effective in elderly patients. Ann Surg Oncol 2017; 24: 1997\u20132005.","journal-title":"Ann Surg Oncol"},{"key":"3402_CR20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00270-017-1645-x","volume":"40","author":"A Rauch","year":"2017","unstructured":"Rauch A, Cazzato RL, Garnon J, et al. MRI\u2013guided cryoablation of in\u2013transit metastases from cutaneous melanoma: a brief report on a preliminary experience. Cardiovasc Intervent Radiol 2017; 40: 1285\u20139.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3402_CR21","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1097\/DSS.0000000000000702","volume":"42","author":"AR Mangold","year":"2016","unstructured":"Mangold AR, Skinner R, Dueck AC, Sekulic A, Pockaj BA. Risk factors predicting positive margins at primary wide local excision of cutaneous melanoma. Dermatol Surg 2016; 42: 646\u201352.","journal-title":"Dermatol Surg"},{"key":"3402_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1245\/s10434-014-4100-0","volume":"22","author":"RL Read","year":"2015","unstructured":"Read RL, Haydu L, Saw RPM, et al. In\u2013transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy. Ann Surg Oncol 2015; 22: 475\u201381.","journal-title":"Ann Surg Oncol"},{"key":"3402_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jaad.2016.05.034","volume":"75","author":"J Zhang","year":"2016","unstructured":"Zhang J, Miller CJ, Sobanko JF, Shin TM, Etzkorn JR. Frequency of and factors associated with positive or equivocal margins in conventional excision of atypical intraepidermal melanocytic proliferations (AIMP): a single academic institution cross\u2013sectional study. J Am Acad Dermatol 2016; 75: 688\u201395.","journal-title":"J Am Acad Dermatol"},{"key":"3402_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jaad.2017.03.025","volume":"77","author":"CJ Miller","year":"2017","unstructured":"Miller CJ, Shin TM, Sobanko JF, et al. Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas. J Am Acad Dermatol 2017; 77: 333\u201340.e1.","journal-title":"J Am Acad Dermatol"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2018.3402\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:19:23Z","timestamp":1741191563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3402"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2018.3402","relation":{},"ISSN":["1952-4013"],"issn-type":[{"type":"electronic","value":"1952-4013"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"20 Februar 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 Januar 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}